1st Quarter - Report
THE OB-C GROUP, LLC for EMERGENT BIOSOLUTIONS INC.
Firm
Client
Income
$30,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
*Issues related to Priority Voucher programs *Opioid and heroin addiction legislation, naloxone access, co-prescribing/opioid prescribing guildlines.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID HEIL | — |
| THOMAS J KEATING | — |
| DANIEL KIDERA | — |
| ROBERT H MARSH | — |
| PATRICIA A NELSON | — |
| LAWRENCE F O'BRIEN, III | — |
| ROBERT G STEVENSON | — |
Budget/Appropriations BUD
H.R. 6074-Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020 S.3548 Cares Act FY 2021 Appropriations :Provisions related to development, acquisition and Stockpiling of medical countermeasures for the US Government. NDAA: provisions related to biological and chemical defense
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID HEIL | — |
| THOMAS J KEATING | — |
| DANIEL KIDERA | — |
| ROBERT H MARSH | — |
| PATRICIA A NELSON | — |
| LAWRENCE F O'BRIEN, III | — |
| ROBERT G STEVENSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.